Companion Animal Ear Infection Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Companion Animal Ear Infection Treatment Market is segmented by Product Type (Antibacterial, Antifungal, Corticosteroids, and Other Product Types), Disease Type (Otitis Externa, Otitis Media, Otitis Interna), Animal Type (Dogs, Cats, and Other Animal Types), Mode of Administration (Topical, Oral, and Otic), and Geography (North America, Europe, Asia-Pacific and Rest of World). The report offers the value (in USD million) for the above segments.

Companion Animal Ear Infection Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Companion Animal Ear Infection Treatment Market Size

Companion Animal Ear Infection Treatment Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
CAGR 6.00 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

Companion Animal Ear Infection Treatment Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Companion Animal Ear Infection Treatment with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Companion Animal Ear Infection Treatment Market Analysis

The Companion Animal Ear Infection Treatment Market is expected to register a CAGR of 6% during the forecast period.

  • The COVID-19 pandemic was an unprecedented health concern and significantly impacted the companion animal ear infection treatment market. Due to the COVID-19 pandemic outbreak, supply chain disruptions and shortages of veterinary medicines were observed in several countries, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine for the treatment of COVID-19. For instance, in November 2021, the European Medicines Agency (EMA) issued guidance for companies responsible for veterinary medicines concerning adaptations to the regulatory framework, primarily to address the challenges faced during this pandemic. Thus, the increasing initiatives taken by government organizations during the pandemic regarding the adaptations of the regulatory framework for veterinary medicines impacted market growth. In addition, an article published by the National Center for Biotechnology Information (NCBI) in April 2021 discussed the toll of the COVID-19 pandemic on the veterinary healthcare industry. It showed how socially isolated veterinary medicine practice hurt personnel. The restricted studies and practices related to veterinary medicines also raised operating costs by 0.5% during the pandemic, necessitating a further increase in professional fees, thereby impacting market growth.Therefore, looking at the overall scenario, it was observed that the COVID-19 pandemic had a significant impact on the market studied. However, currently, the market has reached its pre-pandemic nature in terms of the demand for companion animal ear infection products and is expected to witness healthy growth during the forecast period.
  • The market's growth can be attributed to the increasing prevalence of ear infections in companion animals, the growing number of pet and animal healthcare services, and an increasing number of pet adoptions.
  • The increasing prevalence of ear infections in companion animals drives the demand for ear infection treatment. For instance, according to the article published by the Royal Veterinary College, University of London, in September 2021, one in every 14 dogs in the United Kingdom (7.3%) suffers from an ear infection yearly. As per the same source, dogs aged over one year are at higher risk of ear infections than those under one.
  • Furthermore, the People's Dispensary for Sick Animals (PDSA) 2022 findings revealed that 52% of the United Kingdom adults owned a pet in 2022, and 27% of United Kingdom adults have a dog, with an estimated population of 10.2 million pet dogs. Also, 24% of the United Kingdom's adult population has a cat, with an estimated population of 11.1 million pet cats. Thus, the statistics indicate that the burden of ear infections in companion animals can increase with the growing pet population, thereby increasing the demand for ear infection treatment products.
  • Moreover, government organizations' active participation in increasing awareness regarding companion animal infection treatment products is also increasing market growth. For instance, in July 2021, the US Food and Drug Administration (USFDA) launched a new resource to improve transparency and communication with veterinarians, animal producers, and consumers about safety-related labeling changes made to FDA-approved animal drug products, including animal ear products.
  • Such studies indicate the growing burden of ear infections in companion animals, boosting the demand for ear infection treatment. However, the lack of pet care and the side effects of ear infection treatment in companion animals hinder the market growth.

Companion Animal Ear Infection Treatment Industry Overview

The companion animal ear infection treatment market is moderately competitive, with the presence of few major players. The market players are implementing various strategies such as acquisitions, mergers, and product launches to secure their position in the global market. These companies include Zoetis Inc., Elanco Animal Health Incorporated, Dechra Pharmaceuticals PLC, Merck & Co., Inc., and Virbac Corporation, among others.

Companion Animal Ear Infection Treatment Market Leaders

  1. Zoetis Inc.

  2. Dechra Pharmaceuticals PLC

  3. Merck & Co., Inc.

  4. Virbac Corporation

  5. Elanco Animal Health Incorporated

  6. *Disclaimer: Major Players sorted in no particular order
Companion Animal Ear Infection Treatment Concentration
Need More Details on Market Players and Competiters?
Download PDF

Companion Animal Ear Infection Treatment Market News

  • May 2022: Ceva Santé Animale (Ceva) acquired Artemis Technologies Inc., a Canadian manufacturer of oral rabies vaccines. This strategic move not only strengthens Ceva's market presence but also extends its footprint into the North American segment.
  • January 2021: Boehringer Ingelheim received marketing authorization from the European Medicine Agency (EMA) and the European Commission for its NexGard Combo topical solution for cats. NexGard Combo eliminates fleas, ticks, and ear mites, prevents heartworm disease, and treats hookworm, roundworm, vesical worm, lungworm, and tapeworm infections.

Companion Animal Ear Infection Treatment Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Ear Infection in Companion Animals
    • 4.2.2 Growing Pet and Animal Healthcare Services
  • 4.3 Market Restraints
    • 4.3.1 Lack of Pet Care and Side Effects of Medications
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product Type
    • 5.1.1 Antibacterial
    • 5.1.1.1 Aminoglycosides
    • 5.1.1.2 Fluoroquinolones
    • 5.1.1.3 Other Antibacterial Products
    • 5.1.2 Antifungal
    • 5.1.3 Corticosteroids
    • 5.1.4 Other Product Types
  • 5.2 By Disease Type
    • 5.2.1 Otitis Externa
    • 5.2.2 Otitis Media
    • 5.2.3 Otitis Interna
  • 5.3 By Animal Type
    • 5.3.1 Dogs
    • 5.3.2 Cats
    • 5.3.3 Other Animal Types
  • 5.4 By Mode of Administration
    • 5.4.1 Topical
    • 5.4.2 Oral
    • 5.4.3 Otic
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Rest of World

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Vetoquinol SA
    • 6.1.2 Zoetis Inc.
    • 6.1.3 Elanco Animal Health Incorporated
    • 6.1.4 Dechra Pharmaceuticals PLC
    • 6.1.5 Merck & Co., Inc.
    • 6.1.6 Virbac
    • 6.1.7 Cosmos Corporation
    • 6.1.8 Pet King Brands, Inc.
    • 6.1.9 Nusentia
    • 6.1.10 Boehringer Ingelheim International GmbH
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Companion Animal Ear Infection Treatment Industry Segmentation

Companion animal ear infection treatment encompasses veterinary diagnosis, ear cleansing, and the administration of prescribed antibiotics or antifungals guided by professional expertise for recovery and preventive care.

The market is segmented by product type (antibacterial, antifungal, corticosteroids, and other product types), disease type (otitis externa, otitis media, and otitis interna), animal type (dogs, cats, and other animal types), mode of administration (topical, oral, and otic), and geography (North America, Europe, Asia-Pacific and Rest of World). 

The report offers the value (USD) for the above segments.

By Product Type Antibacterial Aminoglycosides
Fluoroquinolones
Other Antibacterial Products
Antifungal
Corticosteroids
Other Product Types
By Disease Type Otitis Externa
Otitis Media
Otitis Interna
By Animal Type Dogs
Cats
Other Animal Types
By Mode of Administration Topical
Oral
Otic
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of World
Need A Different Region or Segment?
Customize Now

Companion Animal Ear Infection Treatment Market Research FAQs

What is the current Global Companion Animal Ear Infection Treatment Market size?

The Global Companion Animal Ear Infection Treatment Market is projected to register a CAGR of 6% during the forecast period (2025-2030)

Who are the key players in Global Companion Animal Ear Infection Treatment Market?

Zoetis Inc., Dechra Pharmaceuticals PLC, Merck & Co., Inc., Virbac Corporation and Elanco Animal Health Incorporated are the major companies operating in the Global Companion Animal Ear Infection Treatment Market.

Which is the fastest growing region in Global Companion Animal Ear Infection Treatment Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Companion Animal Ear Infection Treatment Market?

In 2025, the North America accounts for the largest market share in Global Companion Animal Ear Infection Treatment Market.

What years does this Global Companion Animal Ear Infection Treatment Market cover?

The report covers the Global Companion Animal Ear Infection Treatment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Companion Animal Ear Infection Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Companion Animal Ear Infection Treatment Industry Report

Statistics for the 2025 Companion Animal Ear Infection Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Companion Animal Ear Infection Treatment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Companion Animal Ear Infection Treatment Report Snapshots